CN111887332A - 一种解酒护肝益肠魔芋巧克力及其制备方法 - Google Patents
一种解酒护肝益肠魔芋巧克力及其制备方法 Download PDFInfo
- Publication number
- CN111887332A CN111887332A CN202010778100.2A CN202010778100A CN111887332A CN 111887332 A CN111887332 A CN 111887332A CN 202010778100 A CN202010778100 A CN 202010778100A CN 111887332 A CN111887332 A CN 111887332A
- Authority
- CN
- China
- Prior art keywords
- parts
- chocolate
- alcohol
- konjak
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920002752 Konjac Polymers 0.000 title claims abstract description 69
- 235000010485 konjac Nutrition 0.000 title claims abstract description 69
- 235000019219 chocolate Nutrition 0.000 title claims abstract description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 210000004185 liver Anatomy 0.000 title claims abstract description 45
- 230000000694 effects Effects 0.000 title claims abstract description 39
- 210000000936 intestine Anatomy 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 73
- 239000000843 powder Substances 0.000 claims abstract description 40
- 239000003814 drug Substances 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 23
- 229940110456 cocoa butter Drugs 0.000 claims abstract description 16
- 235000019868 cocoa butter Nutrition 0.000 claims abstract description 16
- 235000009470 Theobroma cacao Nutrition 0.000 claims abstract description 13
- 230000002075 anti-alcohol Effects 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 230000002443 hepatoprotective effect Effects 0.000 claims abstract description 3
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 33
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 33
- 239000000252 konjac Substances 0.000 claims description 33
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 26
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 26
- 244000010000 Hovenia dulcis Species 0.000 claims description 19
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 19
- 241000219780 Pueraria Species 0.000 claims description 17
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 17
- 229930003944 flavone Natural products 0.000 claims description 17
- 150000002212 flavone derivatives Chemical class 0.000 claims description 17
- 235000011949 flavones Nutrition 0.000 claims description 17
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 17
- 244000163122 Curcuma domestica Species 0.000 claims description 16
- 235000003373 curcuma longa Nutrition 0.000 claims description 16
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 15
- 229920001202 Inulin Polymers 0.000 claims description 15
- 229940029339 inulin Drugs 0.000 claims description 15
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 235000013976 turmeric Nutrition 0.000 claims description 15
- 241000237502 Ostreidae Species 0.000 claims description 14
- 235000020636 oyster Nutrition 0.000 claims description 14
- 208000007848 Alcoholism Diseases 0.000 claims description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 13
- 229930003268 Vitamin C Natural products 0.000 claims description 13
- 201000007930 alcohol dependence Diseases 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 13
- 235000019158 vitamin B6 Nutrition 0.000 claims description 13
- 239000011726 vitamin B6 Substances 0.000 claims description 13
- 235000019154 vitamin C Nutrition 0.000 claims description 13
- 239000011718 vitamin C Substances 0.000 claims description 13
- 229940011671 vitamin b6 Drugs 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 10
- 239000002002 slurry Substances 0.000 claims description 10
- 235000021552 granulated sugar Nutrition 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000007670 refining Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 abstract description 14
- 210000002784 stomach Anatomy 0.000 abstract description 12
- 238000010521 absorption reaction Methods 0.000 abstract description 11
- 238000000354 decomposition reaction Methods 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 4
- 230000002496 gastric effect Effects 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 238000012827 research and development Methods 0.000 abstract description 2
- 230000009897 systematic effect Effects 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 230000006378 damage Effects 0.000 description 12
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 8
- 230000035622 drinking Effects 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 210000005095 gastrointestinal system Anatomy 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- 244000046146 Pueraria lobata Species 0.000 description 4
- 235000010575 Pueraria lobata Nutrition 0.000 description 4
- 235000012754 curcumin Nutrition 0.000 description 4
- 229940109262 curcumin Drugs 0.000 description 4
- 239000004148 curcumin Substances 0.000 description 4
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 3
- 108010087806 Carnosine Proteins 0.000 description 3
- 206010019133 Hangover Diseases 0.000 description 3
- 241001598107 Imperata Species 0.000 description 3
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 244000197580 Poria cocos Species 0.000 description 3
- 235000008599 Poria cocos Nutrition 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 3
- 229940044199 carnosine Drugs 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000020717 hawthorn extract Nutrition 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
- A23G1/48—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
- A23G1/40—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
- A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
- A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
- A23G1/44—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Fruits And Vegetables (AREA)
Abstract
本发明公开了一种解酒护肝益肠魔芋巧克力及其制备方法，按重量份原料配比计，所述解酒护肝益肠魔芋巧克力由以下原料组成：可可脂15－20份、可可粉32－70份、魔芋精粉7－20份、解酒主药1－4份、保肝主药0.05－1份和可接受的辅料。本发明从食品科学、生理科学和***学的研发角度上，开发了一款具有阻吸收、促分解、护肠胃的多通路、易食用的魔芋巧克力解酒产品，通过魔芋精粉与巧克力配合，添加促进酒精分解的解酒主药，辅以护肝主药，具有保护胃肠粘膜、阻碍酒精吸收、促进乙醇分解、抗氧化、抗炎症、改善肠道菌群、减轻酒精对胃、肠、肝的不良影响的作用。
Description
技术领域
本发明涉及食品技术领域，特别涉及一种解酒护肝益肠魔芋巧克力及其制备方法。
背景技术
随着物质生活水平的提高，应酬交际范围的扩大，含酒精饮料的消耗量也在增加，近年来，成人酒精中毒的发生率也相应升高。众所周知，长期饮酒可造成全身多***的损伤，包括肠胃***、肝脏、神经***等，尤其很容易形成酒精性脂肪肝，因此，解酒护肝益肠的功能性产品成为社会所需。目前已有很多解酒护肝类中药和保健品，证明对减少酒精损伤肝原纤维，加快乙醇分解，减少引发酒精肝具有疗效，但作用路径单一，缺乏全身多器官的***防护作用。单一解酒只能减少对肝脏的伤害，有的只是缓解症状，起效慢。
为了解决现有解酒产品功能单一的问题，科研人员对此进行了大量研究，中国专利CN109045273A公开了一种重要解酒组合物及制备方法，其组合物主要包括以下原料：葛根提取物、枳椇子提取物、酸枣仁提取物、可可茶提取物、山楂提取物、白茅根提取物、茯苓提取物、魔芋粉、肌肽、奶粉、麦芽糊精、葡萄糖、乳糖、柠檬酸钠、食用香精、硬脂酸镁。在该配料中，主要以葛根提取物和枳椇子提取物为解酒主药成分，因此其含量占比较大，酸枣仁提取物主治补肝，宁心，敛汗，生津，用于虚烦不眠，惊悸多梦，体虚多汗，津伤口渴，可可茶提取物主含可可豆碱，被人体吸收后具有镇静中枢神经的作用，山楂提取物具有增加心肌收缩力，增加心输出量，减慢心率的作用，白茅根提取物具有凉血止血，清热利尿的作用，茯苓提取物的主要成分是多糖(主要为茯苓糖，含量达到84％)、三萜和脂肪酸类，用于水肿尿少，痰饮眩悸，脾虚食少，便溏泄泻，心神不安，惊悸失眠，具有增强生理活性，刺激人体免疫***的功能恢复的作用，其余魔芋粉、肌肽、麦芽糊精、葡萄糖、乳糖、柠檬酸钠、食用香精和硬脂酸镁均为添加剂和辅料，这些添加剂和辅料与奶片一起，共同组合得到奶片型饮片，该奶片型饮片的作用特点为：从肠胃减缓酒精吸收－保护酒精性肝损伤——减缓中枢异常兴奋——环节肌肉迟缓三个方面，实现解酒，助肌肉运动和安神三管齐下的解酒效果，主要由葛根、枳椇子、酸枣仁、可可茶提取物、山楂、白茅根、茯苓、肌肽组成，以达到预防酒精中毒的目的，加以保肝、减缓中枢异常兴奋、环节肌肉迟缓的功效(该说明书第0019段)。
然而，该中药组合物在解酒时侧重于改善中枢失调和缓解肌肉松弛，忽略了酒精对肠胃***的损伤，虽然该中药组合物中加入了一些益肠胃的组分，例如魔芋粉，但其添加量极少，不足以缓解和治疗酒精对肠胃***的损伤，肠胃***的损坏直接影响人体整个***的运行，肠胃***受损者常出现多种并发疾病，例如胃出血、胃溃疡、胃癌、肠炎等，因此不得不引起重视。
发明内容
本发明的发明目的在于：针对上述存在的问题，提供一种解酒护肝益肠魔芋巧克力及其制备方法，本发明从食品科学、生理科学和***学的研发角度上，开发了一款具有阻吸收、促分解、护肠胃的多通路、易食用的魔芋巧克力解酒产品，通过魔芋精粉与巧克力配合，添加促进酒精分解的解酒主药，辅以护肝主药，发挥联合成分的保护胃肠粘膜、阻碍酒精吸收、促进乙醇分解、抗氧化、抗炎症、改善肠道菌群、减轻酒精对胃、肠、肝的不良影响的作用。
本发明采用的技术方案如下：一种解酒护肝益肠魔芋巧克力，其特征在于，按重量份原料配比计，所述解酒护肝益肠魔芋巧克力由以下原料组成：可可脂15－20份、可可粉32－70份、魔芋精粉7－20份、解酒主药1－4份、保肝主药0.05－1份和可接受的辅料。
在本发明的解酒护肝益肠魔芋巧克力中，魔芋精粉可以阻酒吸收和护肠胃，解酒主药可以是葛根黄酮，也可以是枳椇子提取物，还可以是其他例如肉豆蔻、菊花、苦参等常用的具有解酒作用的成分，保肝主药可以是姜黄，也可以是牡蛎肽，还可以是其他例如党参、黄芪、百合、薏米、田七等常用的具有解酒作用的成分，可接受的辅料包括维生素、淀粉、香精、柠檬酸钠等常用的添加辅料。
在本发明中，所述解酒主药为葛根黄酮提取物或/和枳椇子提取物。
进一步，所述葛根黄酮提取物的含量为0.5－2份，所述枳椇子提取物的含量为0.5－2份。
在本发明中，所述保肝主药为姜黄或/和牡蛎肽。
进一步，所述护肝主药为姜黄和牡蛎肽，所述姜黄含量0.05－1份，所述牡蛎肽含量为0.01－0.1份。
在本发明中，所述辅料包括维生素C或/和维生素B6。
进一步，所述维生素C的含量为0.01－0.5份，所述维生素B6的含量为0.005－0.05份。
进一步，所述辅料中还含有菊粉，所述菊粉的含量为2－6份。
在本发明中，所述解酒护肝益肠魔芋巧克力由以下原料组成：可可脂15－20份、可可粉32－70份、魔芋精粉7－20份、菊粉2－6份、葛根黄酮提取物0.5－2份、枳椇子提取物0.5－2份、姜黄0.05－1份、维生素C为0.01－0.5份、维生素B6为0.005－0.05份、牡蛎肽为0.01－0.1份和适量的调味剂。
进一步，所述调味剂包括白砂糖，所述白砂糖的含量为30－50份。
本发明的解酒护肝益肠魔芋巧克力的制备方法，其特征在于，包括以下步骤：
S1、将魔芋精粉、菊粉、葛根黄酮提取物、枳椇子提取物、姜黄、维生素C和维生素B6案设计的重量份称取，然后混合均匀，得到魔芋巧克力辅料；
S2、将可可粉、可可脂和调味剂按设计的重量份称取，然后混合均匀，经精磨、精炼、调温处理后，得到巧克力浆料；
S3、将巧克力辅料与巧克力浆料在35－60℃保温条件下搅拌混合均匀，然后经调温、浇模、振模、硬化、脱模、挑选、包装后，获得解酒护肝益肠魔芋巧克力产品。
在本发明的配方中，以葛根黄酮、枳椇子为解酒主药，葛根是临床上用以治疗急性酒精性中毒的常用药材，枳椇子具有“解酒毒、清湿热、除烦止渴”的功效，用于“酒精中毒、烦渴呕逆，二便不利”等酒精中毒症状，与葛根配伍，起到相辅相成的作用。为促进解酒效果，辅助维生素C和维生素B6，提供肝脏解酒动力，减少肝脏被酒精伤害。配方中，中药姜黄，性味辛、苦，温，归脾、肝经，姜黄中的姜黄素具有抗氧化作用，同时可促进肝脏中乙醛转化成乙酸，临床大量的资料证实，牡蛎肽对实验性肝损伤具有很好的保护作用，因此以姜黄和牡蛎来作为保护肝脏的主要成分。
在本发明中，本发明最大的创新在于：通过魔芋精粉与巧克力配合，添加促进酒精分解的解酒主药，辅以护肝主药，发挥联合多重作用，具体地说，在配方中，巧克力中的可可脂含有丰富的多酚，具有抗氧化功能，同时可促进姜黄素、葛根黄酮等成分的吸收，巧克力中的可可脂和砂糖可为肝脏中酒精分解代谢提供充足的能量；魔芋精粉中葡甘露聚糖(KGM)具有很强的吸水性，吸收后形成粘稠的水凝胶，覆盖在胃粘膜上可有效阻碍酒精的吸收，KGM到达结肠部位后，在肠道微生物作用下发酵产酸，生成乙酸、丙酸、丁酸等多种短链脂肪酸，同时促进肠道双歧杆菌、乳杆菌等有益菌增殖。本发明中将魔芋精粉与巧克力有机融合，不仅极大改善了魔芋精粉的口感，克服了高含量魔芋精粉口感差的缺陷，还适当降低了魔芋精粉的凝聚性，增加了其水凝胶的流动性，有效加速了魔芋精粉在胃中溶胀和分布；配方中加入菊粉，菊粉含大量菊糖，菊糖是肠道益生菌快速利用的发酵底物，公认的益生元，有助于减少饮酒对肠道菌群的破坏。
通过以上几种生理功效成分的有机组合，在胃、肠、肝中发挥协同作用，帮助饮酒人群减少酒精吸收，减轻肝脏解酒负担，在维生素、可可脂协同作用下加速酒精代谢、促进机体恢复，在黄酮、姜黄素协同抗氧化保护肝脏，减少了酒精对肝的损伤，同时通过魔芋精粉和菊糖来促进肠道益生菌生长，保护肠道微生态，起到显著的阻碍酒精吸收、促进酒精分解、保护肝脏和肠道微生态，从而多***联合降低饮酒伤害、缓解酒后不适的作用。
综上所述，由于采用了上述技术方案，本发明的有益效果是：
1、本发明通过魔芋精粉与巧克力配合，添加促进酒精分解的解酒主药，辅以护肝主药，发挥联合多重作用，而且，魔芋精粉与巧克力有机融合，不仅极大改善了魔芋精粉的口感，克服了高含量魔芋精粉口感差的缺陷，还适当降低了魔芋精粉的凝聚性，增加了其水凝胶的流动性，有效加速了魔芋精粉在胃中溶胀和分布。
2、本发明通过上述几种生理功效成分的有机组合，在维生素、可可脂协同作用下加速酒精代谢、促进机体恢复，在黄酮、姜黄素协同作用下抗氧化保护肝脏，减少了酒精对肝的损伤，同时通过魔芋精粉和菊糖来促进肠道益生菌生长，保护肠道微生态，起到显著的阻碍酒精吸收、促进酒精分解、保护肝脏和肠道微生态，从而多***联合降低饮酒伤害、缓解酒后不适的作用。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。
实施例1
一种解酒护肝益肠魔芋巧克力的制备方法，包括以下步骤(重量份)：
S1、将8份魔芋精粉、6份菊粉、1份葛根黄酮提取物、0.5份枳椇子提取物、1份姜黄、0.05份牡蛎肽、0.1份维生素C、0.01份维生素B6称量后，混合均匀，制备得到魔芋巧克力辅料；
S2、将45份可可粉、15份可可脂、50份白砂糖混合，然后经精磨、精炼、调温，形成巧克力浆料；
S3、将S1中制得的可可脂巧克力辅料12份与S2制得的巧克力浆料80份在40℃保温条件下搅拌混合均匀，然后调温、浇模、振模、硬化、脱模、挑选、包装，获得魔芋巧克力。
实施例2
一种解酒护肝益肠魔芋巧克力的制备方法，包括以下步骤(重量份)：
S1、将10份魔芋精粉、5份菊粉、1.5份葛根黄酮提取物、1.5份枳椇子提取物、0.1份姜黄、0.01份牡蛎肽、0.2份维生素C、0.02份维生素B6等原料称量后，混合均匀，制备得到魔芋巧克力辅料；
S2、将50份可可粉、20份可可脂、30份白砂糖或甜味剂混合，然后经精磨、精炼、调温，形成巧克力浆料；
S3、将S1中制得的可可脂巧克力辅料20份与S2制得的巧克力浆料70份在45℃保温条件下搅拌混合均匀，然后调温、浇模、振模、硬化、脱模、挑选、包装，获得魔芋巧克力。
实施例3
一种解酒护肝益肠魔芋巧克力的制备方法，包括以下步骤(重量份)：
S1、将20份魔芋精粉、2份菊粉、2份葛根黄酮提取物、1份枳椇子提取物、1份姜黄、0.1份牡蛎肽、0.5份维生素C、0.04份维生素B6等原料称量后，混合均匀，制备得到魔芋巧克力辅料；
S2、将60份可可粉、20份可可脂、40份白砂糖或甜味剂混合，然后经精磨、精炼、调温，形成巧克力浆料；
S3、将S1中制得的可可脂巧克力辅料30份与S2制得的巧克力浆料60份在60℃保温条件下搅拌混合均匀，然后调温、浇模、振模、硬化、脱模、挑选、包装，获得魔芋巧克力。
实验案例
为验证本发明的效果，采用雄性昆明种小鼠(SPF级)，65只，体重范围25－30g，鼠龄7周龄－12周龄。随机分为对照组1(蒸馏水)、对照组2(纯巧克力)、实施例1组、实施例2组、实施例3组。分3次试验，每次间隔1周。实验前，实验大鼠断食12小时，可自由饮水，试验开始五组大鼠分别灌胃等量的蒸馏水、纯巧克力、实施例1、实施例2和实施例3，20min后，灌胃52％(V/V)江津白酒12ml/kg BW(第一次)。恢复1周后重复此实验，灌胃白酒剂量为16ml/kg BW(第二次)；再恢复1周后重复此实验，灌胃白酒剂量为20ml/kg BW(第三次)，每次灌胃后，观察醉酒率、醒酒时间、24h内死亡率，60min后尾部采血测乙醇含量。收集灌胃后第三天的粪便，用于检测粪便菌群组成，实验结果见下表1和表2。
表1魔芋巧克力阻酒防醉效果分析
表2魔芋巧克力对酒后肠道菌群的影响(酒精剂量16ml/kg BW)
由表1可以得到，灌胃本发明的3种实施例配方的魔芋巧克力均能有效降低醉酒率，缩短醒酒时间，降低酒后血液中酒精含量。同时从表2发现，3种实施例均可有效降低酒精对肠道菌群的损害，降低大肠杆菌、肠球菌等有害菌数量，增加双歧杆菌、乳酸菌数量，保护肠道环境健康。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明的保护范围之内。
Claims (10)
1.一种解酒护肝益肠魔芋巧克力，其特征在于，按重量份原料配比计，所述解酒护肝益肠魔芋巧克力由以下原料组成：可可脂15－20份、可可粉32－70份、魔芋精粉7－20份、解酒主药1－4份、护肝主药0.05－1份和可接受的辅料。
2.如权利要求1所述的解酒护肝益肠魔芋巧克力，其特征在于，所述解酒主药为葛根黄酮提取物或/和枳椇子提取物。
3.如权利要求2所述的解酒护肝益肠魔芋巧克力，其特征在于，所述解酒主药为葛根黄酮提取物和枳椇子提取物，所述葛根黄酮提取物的含量为0.5－2份，所述枳椇子提取物的含量为0.5－2份。
4.如权利要求1所述的解酒护肝益肠魔芋巧克力，其特征在于，所述护肝主药为姜黄和牡蛎肽，所述姜黄含量0.05－1份，所述牡蛎肽含量为0.01－0.1份。
5.如权利要求1所述的解酒护肝益肠魔芋巧克力，其特征在于，所述辅料包括维生素C或/和维生素B6。
6.如权利要求5所述的解酒护肝益肠魔芋巧克力，其特征在于，所述辅料包括维生素C和维生素B6，所述维生素C的含量为0.01－0.5份，所述维生素B6的含量为0.005－0.05份。
7.如权利要求1所述的解酒护肝益肠魔芋巧克力，其特征在于，所述辅料中还含有益肠成分菊粉，所述菊粉的含量为2－6份。
8.如权利要求1所述的解酒护肝益肠魔芋巧克力，其特征在于，所述解酒护肝益肠魔芋巧克力由以下原料组成：可可脂15－20份、可可粉32－70份、魔芋精粉7－20份、菊粉2－6份、葛根黄酮提取物0.5－2份、枳椇子提取物0.5－2份、姜黄0.05－1份、维生素C为0.01－0.5份、维生素B6为0.005－0.05份、牡蛎肽0.01－0.1份和适量的调味剂。
9.如权利要求8所述的解酒护肝益肠魔芋巧克力，其特征在于，所述调味剂包括白砂糖，所述白砂糖的含量为30－50份。
10.如权利要求9所述的解酒护肝益肠魔芋巧克力的制备方法，其特征在于，包括以下步骤：
S1、将魔芋精粉、菊粉、葛根黄酮提取物、枳椇子提取物、姜黄、维生素C、维生素B6和牡蛎肽按设计的重量份称取，然后混合均匀，得到魔芋巧克力辅料；
S2、将可可粉、可可脂和调味剂按设计的重量份称取，然后混合均匀，经精磨、精炼、调温处理后，得到巧克力浆料；
S3、将巧克力辅料与巧克力浆料在35－60℃保温条件下搅拌混合均匀，然后经调温、浇模、振模、硬化、脱模、挑选、包装后，获得解酒护肝益肠魔芋巧克力产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010778100.2A CN111887332A (zh) | 2020-08-05 | 2020-08-05 | 一种解酒护肝益肠魔芋巧克力及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010778100.2A CN111887332A (zh) | 2020-08-05 | 2020-08-05 | 一种解酒护肝益肠魔芋巧克力及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111887332A true CN111887332A (zh) | 2020-11-06 |
Family
ID=73246679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010778100.2A Pending CN111887332A (zh) | 2020-08-05 | 2020-08-05 | 一种解酒护肝益肠魔芋巧克力及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111887332A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114868825A (zh) * | 2022-04-29 | 2022-08-09 | 四川盟牙膳用食品科技有限公司 | 一种含玉米低聚肽的代糖巧克力及其制备方法 |
| CN117770339A (zh) * | 2024-02-05 | 2024-03-29 | 宁德九展农业有限公司 | 一种解酒护肝作用的双基巧克力制备方法 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103431388A (zh) * | 2013-08-22 | 2013-12-11 | 四川魔力科技有限公司 | 一种解酒食品及制备方法 |
| CN103948854A (zh) * | 2014-04-18 | 2014-07-30 | 夏澍 | 解酒护肝保健品及其制备方法 |
| CN104172159A (zh) * | 2014-07-24 | 2014-12-03 | 北京中泰天和科技有限公司 | 一种对酒精性肝损伤具有辅助保护作用的组合物及其制备方法 |
| CN105475584A (zh) * | 2015-12-17 | 2016-04-13 | 安徽尚可艾食品有限公司 | 一种富硒保健巧克力 |
| CN105581198A (zh) * | 2015-12-17 | 2016-05-18 | 佛山市三水健力宝贸易有限公司 | 一种醒酒维生素营养强化饮料的配方及生产工艺 |
| CN108770971A (zh) * | 2018-05-24 | 2018-11-09 | 佳木斯大学 | 一种解酒护肝巧克力及其制备方法 |
| CN110946280A (zh) * | 2019-12-09 | 2020-04-03 | 董金龙 | 一种解酒护肝健脑的*酒肽及解酒护肝健脑*酒肽保健食品 |
-
2020
- 2020-08-05 CN CN202010778100.2A patent/CN111887332A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103431388A (zh) * | 2013-08-22 | 2013-12-11 | 四川魔力科技有限公司 | 一种解酒食品及制备方法 |
| CN103948854A (zh) * | 2014-04-18 | 2014-07-30 | 夏澍 | 解酒护肝保健品及其制备方法 |
| CN104172159A (zh) * | 2014-07-24 | 2014-12-03 | 北京中泰天和科技有限公司 | 一种对酒精性肝损伤具有辅助保护作用的组合物及其制备方法 |
| CN105475584A (zh) * | 2015-12-17 | 2016-04-13 | 安徽尚可艾食品有限公司 | 一种富硒保健巧克力 |
| CN105581198A (zh) * | 2015-12-17 | 2016-05-18 | 佛山市三水健力宝贸易有限公司 | 一种醒酒维生素营养强化饮料的配方及生产工艺 |
| CN108770971A (zh) * | 2018-05-24 | 2018-11-09 | 佳木斯大学 | 一种解酒护肝巧克力及其制备方法 |
| CN110946280A (zh) * | 2019-12-09 | 2020-04-03 | 董金龙 | 一种解酒护肝健脑的*酒肽及解酒护肝健脑*酒肽保健食品 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114868825A (zh) * | 2022-04-29 | 2022-08-09 | 四川盟牙膳用食品科技有限公司 | 一种含玉米低聚肽的代糖巧克力及其制备方法 |
| CN117770339A (zh) * | 2024-02-05 | 2024-03-29 | 宁德九展农业有限公司 | 一种解酒护肝作用的双基巧克力制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110447902B (zh) | 一种具有减肥功效的组合物 | |
| KR102262306B1 (ko) | 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물 | |
| CN112245443A (zh) | 人参皂苷Rg3与Rg5的组合物及其抗肿瘤等药用 | |
| CN104474438A (zh) | 一种促进猪生长及改善肉质的中药组合物 | |
| KR20120002131A (ko) | 울금 추출물을 함유하는 비만 치료 또는 예방용 조성물 | |
| CN111887332A (zh) | 一种解酒护肝益肠魔芋巧克力及其制备方法 | |
| CN112021564A (zh) | 一种用于养护胃肠的组合物及其制备方法和应用 | |
| US20180296615A1 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
| KR102192573B1 (ko) | 생리통 및 피부 트러블의 예방 및 개선용 조성물 | |
| CN107836619A (zh) | 一种具有增强免疫力和抗疲劳作用的牛大力固体饮料及其制备方法 | |
| KR102203657B1 (ko) | 복합추출물을 함유하는 여성 항비만용 조성물 | |
| KR101690369B1 (ko) | 여주 혼합 열수추출물을 유효성분으로 포함하는 항비만용 약학적 조성물 및 이의 제조방법 | |
| CN115053929B (zh) | 一种适合脂肪肝人群的配方奶粉及其制备 | |
| KR20190053108A (ko) | 복합추출물을 함유하는 남성 항비만용 조성물 | |
| KR101350046B1 (ko) | 항비만 효능을 갖는 복합 생약 발효 식초 조성물 및 그 제조방법 | |
| KR102289449B1 (ko) | 고양이 방광염 개선용 조성물 및 이의 제조방법 | |
| CN102511876A (zh) | 山楂红枣浓浆 | |
| CN109730303A (zh) | 一种消食健胃的鸡内金微晶粉冲剂及其制备方法 | |
| CN109452417A (zh) | 一种纯天然清脂减肥茶饮料及其制备方法 | |
| CN101288765A (zh) | 一种消食化积的药物组合及其制备方法 | |
| CN106923335A (zh) | 一种运动营养的功能组合物及应用 | |
| EP4238611A1 (en) | Composition for preventing, improving, or alleviating menstrual symptoms | |
| US10646537B2 (en) | Traditional Chinese medicine for treating abdominal obesity | |
| CN112137112A (zh) | 一种解酒护肝复合食品及其制备方法 | |
| KR101047796B1 (ko) | 인슐린 저항성 개선 효능을 갖는 냉초 추출물 및 이를 유효성분으로 함유하는 제품 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201106 |